- 336 pages
- English
- PDF
- Available on iOS & Android
eBook - PDF
About this book
The book is the first major review of menopause-associated osteoporosis, post WHI. The book has in-depth sections on the pathogenesis, epidemiology, and diagnosis of osteoporosis. The chief focus is on medical prevention and treatment, and includes chapters on hormone replacement therapy, bisphosphonates, selective estrogen receptor modulators (SER
Frequently asked questions
Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
No, books cannot be downloaded as external files, such as PDFs, for use outside of Perlego. However, you can download books within the Perlego app for offline reading on mobile or tablet. Learn more here.
Perlego offers two plans: Essential and Complete
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Postmenopausal Osteoporosis by Andrea R. Genazzani in PDF and/or ePUB format, as well as other popular books in Medicine & Endocrinology & Metabolism. We have over one million books available in our catalogue for you to explore.
Information
Table of contents
- Front Cover
- Contents
- List of contributors
- Preface
- Chapter 1: Magnitude and impact of osteoporosis and fractures
- Chapter 2: Impact of osteoporosis on quality of life and quality of life on osteoporosis: rationale and methodology for accurate assessment
- Chapter 3: Novel signals determining skeletal cell fate and function
- Chapter 4: Sex steroid hormones and bone formation
- Chapter 5: The effect of sex steroids on osteoclast function
- Chapter 6: Calcium and vitamin D: regulation of mineral homeostasis
- Chapter 7: Genetic regulation of bone mass
- Chapter 8: Bone mineral acquisition during infancy and adolescence
- Chapter 9: Osteoporosis: influence of life-style
- Chapter 10: Postmenopausal osteoporosis and dental health
- Chapter 11: Bone quality
- Chapter 12: Diagnosis: clinical, hormonal and biochemical evaluation
- Chapter 13: Advanced imaging assessment of bone quality
- Chapter 14: Quantitative ultrasonometry of bone in the management of postmenopausal women
- Chapter 15: Awareness of osteoporosis and related treatments
- Chapter 16: Intervention thresholds for osteoporosis
- Chapter 17: Vitamin D and calcium supplements
- Chapter 18: Estrogen dose response in bone density and bone histology
- Chapter 19: Effects of oral contraceptive preparation on bone health
- Chapter 20: Hormone replacement therapy
- Chapter 21: New physiologic approach to prevention of postmenopausal osteoporosis
- Chapter 22: Selective estrogen receptor modulators
- Chapter 23: Bisphosphonates in the management of osteoporosis
- Chapter 24: Phytoestrogens: food or drug?
- Chapter 25: Tibolone
- Chapter 26: Understanding the role of aromatizable androgens in bone-sparing
- Chapter 27: Strontium ranelate: a new first-line treatment for patients with postmenopausal osteoporosis
- Chapter 28: Reconciling risks and benefits of hormone replacement therapy in a single outcome: the QALY approach
- Chapter 29: Prevent, treat and maintain: how to optimize the management of postmenopausal osteoporosis
- Chapter 30: Transdermal hormone therapy: effects on bone
- Chapter 31: Progestogens and bone
- Chapter 32: Effect of different dose options of continuous combined hormone therapy on bone and bone marker N-terminal propeptide of type Iprocollagen: results from a long-term study in Finnish postmenopausal women
- Chapter 33: The use of alendronate in osteoporosis treatment: 10-year experience
- Back Cover